Page 8 - Thomas Theuringer News Today

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.GERMANTOWN, Md. & HILDEN, Germany ...

QIAGEN N.V.: QIAGEN Announces 20-F Annual Report Filing for 2020 Results QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2020, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGENs website at https://corporate.qiagen.com/investor-relations/financial-reports About QIAGEN QIAGEN N.V., a Netherlands...

QIAGEN and INOVIO Pharmaceuticals: QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIOs VGX-3100 for Advanced Cervical Dysplasia QIAGENs bioinformatic expertise raises predictive biomarker power in INOVIOs patient selection First-in-class next generation sequencing (NGS) assay designed for use on Illumina NextSeq 550Dx QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an exte...

(2) QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it plans to resubmit in the first quarter of 2021 its QIAreach SARS-CoV-2 Antigen Test to the U.S. Food and Drug Administration for Emergency Use Authorization to detect SARS-CoV-2 antigens in people with active infections in 15 minutes. This comes after QIAGEN decided to proactively withdraw the first submission made in November 2020 for this product to address a chemistry-related issue. QIAGEN believes it has res...

QIAGEN N.V.: QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus QIAGEN started cross-checking variants in May 2020 and continues to conduct biweekly assessments QIAseq SARS-CoV-2 Primer Panel helps with sequencing RNA and identifying mutations QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections and will continue to cl...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

QIAGEN N.V.: QIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility Transaction was well received and significantly oversubscribed by eleven banks QIAGEN will donate margin gains of improved ESG rating to sustainability-linked causes QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard QIA) announced today that it has successfully concluded a syndicated revolving credit facility for EUR 400mn with an interest rate linked to the comp...